Medications for Heart Failure

71 results
  • acetazolamide

    (acetaZOLAMIDE)
    Zydus Pharmaceuticals (USA) Inc.
    Acetazolamide is indicated as an adjunctive treatment for edema related to congestive heart failure and drug use, various forms of epilepsy, and glaucoma. It is also used to prevent or alleviate symptoms of acute mountain sickness in climbers.
  • acetazolamide

    (ACETAZOLAMIDE)
    TRUPHARMA, LLC
    Acetazolamide is indicated as adjunctive treatment for edema due to congestive heart failure and drug-induced edema, centrencephalic epilepsies, various types of glaucoma, and for preventing symptoms of acute mountain sickness in climbers.
  • adreview

    (Iobenguane I-123)
    Medi-Physics Inc.
    AdreView is indicated for detecting primary or metastatic pheochromocytoma and neuroblastoma, and for assessing sympathetic innervation in patients with congestive heart failure (NYHA class II or III, LVEF ≤ 35%). It aids in identifying lower mortality risks but is not for therapy selection or monitoring.
  • aldactone

    (spironolactone)
    Pfizer Laboratories Div Pfizer Inc
    ALDACTONE is indicated for treating NYHA Class III-IV heart failure, hypertension, edema from hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism. It helps increase survival, manage edema, lower blood pressure, and provide preoperative or maintenance therapy for hyperaldosteronism cases.
  • amiloride hydrochloride and hydrochlorothiazide

    (Amiloride Hydrochloride and Hydrochlorothiazide)
    Teva Pharmaceuticals USA, Inc.
    Amiloride hydrochloride and hydrochlorothiazide tablets are used to treat hypertension and congestive heart failure, particularly in patients at risk of hypokalemia. They may be combined with other antihypertensive medications but are not intended for initial therapy of edema or hypertension unless hypokalemia is a concern.
  • atacand

    (Candesartan Cilexetil)
    ANI Pharmaceuticals, Inc.
    ATACAND is indicated for treating hypertension in adults and children aged 1-17, reducing cardiovascular event risks. It is also indicated for heart failure in adults with left ventricular systolic dysfunction (ejection fraction ≤ 40%) to decrease cardiovascular deaths and hospitalizations.
  • atorvastatin calcium

    (ATORVASTATIN CALCIUM)
    Camber Pharmaceuticals, Inc.
    Atorvastatin calcium tablets are indicated for reducing cardiovascular risks in adults and managing cholesterol levels, including primary hyperlipidemia, heterozygous and homozygous familial hypercholesterolemia, primary dysbetalipoproteinemia, and hypertriglyceridemia, as well as in patients with diabetes and multiple coronary heart disease risk factors.
  • atorvastatin calcium

    (Atorvastatin Calcium)
    Lupin Pharmaceuticals Inc
    Atorvastatin calcium is indicated for reducing the risk of myocardial infarction, stroke, and related procedures in adults with risk factors for coronary heart disease, and for lowering LDL cholesterol in patients with hyperlipidemia, familial hypercholesterolemia, and other lipid disorders as an adjunct to diet.
  • atorvastatin calcium

    (Atorvastatin Calcium)
    Teva Pharmaceuticals USA, Inc.
    Atorvastatin calcium is indicated to reduce the risk of heart-related events in adults with risk factors for coronary heart disease and to lower LDL cholesterol levels in adults and pediatric patients with various forms of hyperlipidemia, including familial hypercholesterolemia and dysbetalipoproteinemia.
  • atorvastatin calcium

    (atorvastatin calcium, film coated)
    Rising Pharma Holdings, Inc.
    Atorvastatin calcium is indicated to reduce the risk of heart-related issues in adults with multiple risk factors for coronary heart disease and those with type 2 diabetes. It also lowers LDL cholesterol in patients with primary hyperlipidemia, familial hypercholesterolemia, and other lipid disorders.